Showcasing our AI-powered digital cytotoxicity and cell viability assay, we demonstrate how Nanolive’s high-content live cell imaging can be used to increase confidence in lead candidate selection.
In this webinar, we explore the following drug discovery applications of Nanolive’s LIVE Cell Death Assay – all completely label-free:
- Drug screening in a 96-well plate
- Differentiating between necrotic and apoptotic cell death
- Detecting therapy resistance
Cell Health, Stress and Recovery
- Detecting cell stress before death
- Investigating therapy resistance using the Health Cell Index and Refractive Index imaging
- Monitoring cell recovery from the apoptotic pathway (anastasis)
Speaker: Hope Amos
Scientific Communication Specialist
Read our latest news
Nanolive imaging confirms success of mesoestetic’s new treatment at the subcellular level
We are happy to see that Nanolive imaging has been used to confirm the success of another new therapy, this time treating melasma. In their latest paper “Depigmenting topical therapy based on a synergistic combination of compounds targeting the key pathways involved...
Mitochondrial secretion captured by Nanolive’s live cell imaging in new Cell Metabolism Paper
Congratulations to scientists at Seoul National University who have recently published their work in Cell Metabolism in their article “Mitochondrial fragmentation and donut formation enhance mitochondrial secretion to promote osteogenesis”! The authors characterized...
Nanolive revolutionizing mitochondrial therapy research in Japan: “Seeing is believing”
Nanolive installed the CX-A automated live cell imaging platform at LUCA Science in Sapporo, Japan Nanolive SA announced today the installation of their CX-A imaging platform at LUCA Science’s Research & Development Center in Sapporo, Japan. LUCA Science is...